View this email in your browser ([link removed])
[link removed]
JAMA Study Justifying Drug Price Controls Deeply Flawed, Patient Health Jeopardized if Findings Implemented
NEW BRIEF | May 8, 2024 | Sally Pipes & Wayne Winegarden

To justify price controls, Sanders cites the JAMA study ([link removed]) (“Estimated Sustainable Cost-Based Prices for Diabetes Medicines” by Barber, Gotham and Bygrave) claiming innovative diabetes medicines can be manufactured for $5 a month. Winegarden and Pipes identify numerous flaws that invalidate the study’s results and highlight how the Sanders agenda would put patient health at risk.

Read here . . . ([link removed])
Government shouldn't micromanage nursing homes
Washington Examiner | Sally Pipes | May 5, 2024

The Biden administration ([link removed]) published regulations last month requiring most nursing homes to maintain specific staffing levels. As a result, roughly three in four ([link removed]) nursing homes will have to hire additional personnel.

Read more... ([link removed])

------------------------------------------------------------

Sanders Views Canada's Healthcare Through Rose-Colored Glasses
Newsmax | Sally Pipes | April 30, 2024

Sen. Bernie Sanders’s, I-Vt., assessment of U.S. healthcare during an event ([link removed]) at Harvard’s T.H. Chan School of Public Health earlier this month, was “It is a system not designed to provide health care to all people in a cost-effective way.”

What Sen. Sanders failed to mention is that his preferred model for care delivery — a government-run, single-payer insurance system that bans private coverage for anything considered “medically necessary” — would be so much worse.

Read more... ([link removed])

[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Instagram ([link removed])
** Website ([link removed])
Copyright © 2024 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.